mardi 6 juin 2017

Onco Actu du 6 juin 2017

2.6 Etiologie - Environnement

'Everyday chemicals' linked to cancer [NHS Choices]

4.12 Biopsies liquides

Grail’s $1 Billion Bet on the Perfect Cancer Test [MIT Technology review]

4.2 Dép., diag. & prono. - Génome

Illumina and American Society of Clinical Oncology, Inc. Jointly Donate Thousands of Somatic Interpretations to CIViC to Advance Genomic Medicine [ASCO]

5.12.2 Immunothérapies - CAR-T

Moving on from a trial disaster, Juno reports positive data for JCAR017 — and a death [EndPoints]

5.12.5 Immunothérapies - Pharma

How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss [Forbes]

A Hot Cancer-Drug Race Keeps Getting More Crowded [Bloomberg]

5.12.6 Immunothérapies - AMM

European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for Previously Treated Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy [BMS]

5.2.1 Pharma - Partenariats

Bristol-Myers and Seattle Genetics move a promising flagship combo into PhIII [EndPoints]

Novartis announces ground-breaking collaboration with IBM Watson Health on outcomes-based care in advanced breast cancer [Novartis]

Bristol-Myers Squibb and Seattle Genetics Expand Clinical Collaboration to Evaluate Combination of Opdivo (Nivolumab) and ADCETRIS® (Brentuximab Vedotin) in Pivotal Phase 3 Clinical Trial in Relapsed Hodgkin Lymphoma [BMS]

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies [BMS]

Novartis, IBM Watson Health team up for breast cancer project [Reuters]

5.3 Traitements - FDA, EMA, NICE...

In cancer treatment, there’s more than one way to measure patient benefit [FDA Voice]

5.4 Traitements - Economie

Debunking The Pharmaceutical Research ‘Free Rider’ Myth: A Response To Yu, Helms, And Bach [Health Affairs Blog]

Drug Prices And Medical Innovation: A Response To Yu, Helms, And Bach [Health Affairs Blog]

5.5.2 ASCO (sein)

New gene therapy offers hope against incurable form of breast cancer [The Guardian]

6. Lutte contre les cancers

Big returns on small cancer research investment, study suggests [Reuters]

6.1 Observation

Take a Number: Women With Aggressive Breast Cancer Are Living Longer [NY Times]

6.4 Médico-éco

The Specialists’ Stranglehold on Medicine [NY Times]

6.5 Médecines alternatives

Cassandra Callender’s cancer is progressing, and the quackery didn’t stop it. Let’s hope real medicine can. [Respectful Insolence]

6.6 Publications

Data sharing statements for clinical trials [BMJ]